Tag: CDSCO
Symbiotec Pharmalab Announces ₹1,757 Crore IPO to Fuel Biopharma Growth
Symbiotec Pharmalab, a leading research and development-driven pharmaceutical and biotechnology player, has announced details of its ₹1,757 crore Initial Public Offering (IPO). The public issue...
Pharmacy Council of India Introduces M.Pharm Specialisation in Medical Devices
The Pharmacy Council of India (PCI) has officially notified an amendment to the Master of Pharmacy (M.Pharm) Course Regulations, introducing Medical Devices as a...
Lupin Partners With Tenpoint to Bring YUVEZZI Eye Drops to European Markets
Indian pharmaceutical giant Lupin Limited has struck a licensing deal that will let its subsidiary VISUfarma B.V. sell YUVEZZI™, a presbyopia eye drop, across...
Charles River and Medigen Partner to Advance Next-Generation Enterovirus Vaccine
Charles River Laboratories International, Inc. (NYSE: CRL) has entered a collaboration with Taiwan-based Medigen Vaccine Biologics Corp. (MVC) to support development of MVC's next-generation multivalent enterovirus...
Ipsen Completes Kartos Therapeutics Acquisition to Boost Late-Stage Oncology Pipeline
Ipsen has officially completed its acquisition of KartosTherapeutics, a clinical-stage biopharmaceutical company. The transaction integrates navtemadlin, an investigational, first-in-class oral MDM2 inhibitor in Phase 3 clinical development,...
Union Minister Anupriya Patel announced India Must Move from ‘Pharmacy of the World’ to ‘Laboratory of the World
Addressing the third edition of the IIMA Healthcare Summit 2026 on the theme “Advancing AI in Healthcare,” Union Minister of State for Health &...
